Moreover, available evidence has found that insulin resistance in COPD patients is associated with inflammation mediators such as C-reactive protein (CRP), interleukin-6 (IL-6) and tumour necrosis factor–α [35, 36]. This evidence concerns the gene IL6 and Insulin resistance.